Type 2 Diabetes mellitus T2DM has been suggested to be the most common
metabolic disorder associated with magnesium deficiency which has many adverse
outcomes. The aim of this study was to evaluate plasma Mg in 126 T2DM patients
recruited from Dia
betes Centre in Lattakia, compare them to 70 healthy individuals, and
assess the correlation between plasma Mg and HbA1c as a glycemic control biomarker.
Magnesium was measured using xylidyl blue colorimetric method. HbA1c was measured
using ion-exchange resin separation. The SPSS 19.0 software was used for statistical
analysis. Mean plasma Mg concentrations of the diabetics was significantly lower than
controls (P=0.0001). Plasma magnesium was negatively correlated with HbA1c (r=-0.5,
P=0.0002). Plasma magnesium was below the normal reference range (1.9-2.5 mg/dL) in
47.6% of diabetics and 28.6% of controls. In conclusion, it is important to monitor Mg
levels in both T2DM patients and non-diabetics and take procedures to correct
hypomagnesaemia states.
In this prospective study done in Syria from mars 2014 to
February 2015, Mean serum hemoglobin ,serum hematocrit,
serum ferritin, and the ratio of serum iron to total iron-binding
capacity were investigated in 100 children aged ( 2-11) years.
The
study aimed at assessing the extention of anemia in
giardiasis intestinalis in Syrians children.
This study aims to show the effectiveness of hydroxyl urea in the treatment of
severe forms of sickle-cell anemia.
The study included 30 patients from patients with sickle cell anemia and who
reviewed the Blood clinics in AL- Assad University Hosp
ital .
We had studied patients treated with hydroxy urea for at least 6 months, where it was
compared to blood and clinical variables before and after hydroxy urea treatment.
The results showed an improvement in blood and clinical manifestations , and it was
noted a significant increase in the level of fetal hemoglobin, and a decrease in the level of
hemoglobin and sickle cell after hydroxy urea treatment.
hydroxy urea treatment also led to a clear increase in the level of total hemoglobin,
and a decrease in the value of total bilirubin.
Decrease in the number of the pain episodes that needed hospitalization, and the
number of times of blood transfusion after treatment, too.
This study was carried at Al Assad hospital, Lattakia. It is a retrospective study of uterine leiomyoma patients who had been accepted in the Department of Gynecology during the period between 1/6/2011 and 1/6/2013 .
The study included 103 patients.
We documented information for each patient: age, signs and symptoms, number of pregnancies and births, clinical and vaginal examination, ultrasound, blood tests: hemoglobin, hematocrit and red cell values, and the type of surgical treatment.
The prevalence of uterine leiomyoma in this study was 5.1%.
The most clinical manifestation of uterine leiomyoma was abnormal uterine bleeding (63.1 %).
Hemoglobin was less than 12 g / dL at 59.22% of cases.
Hematocrit was less than 36% at 57.28 % of cases.
This confirms that uterine leiomyoma patients are at high risk of anemia,
(we depended on cut off point of WHO for hemoglobin and hematocrit), and the anemia is by iron deficiency because the average values of red blood cells were less than normal.
Myomectomy is the surgical option among young women who want to reproduce or maintain menstruation, while abdominal and vaginal hysterectomy are surgical options for older women or who have completed their reproductive life .
Blood glucose control reduces the microvascular and macrovascular
complications in patients with diabetes mellitus type II. According to the American Diabetes Association, less than a half of those with diabetes achieve optimal control of blood gluc
ose and target values of HbA1c. Life style modifications is one of the preferences of diabetes management because the potential relationship between diet and diabetic control. So nutrition therapy which given by dietitian and generally lifestyle modifications are considered mainly integrated to traditional medication for disease.
The study included 104 patients with diabetes type II (HbA1c 8% ± 1.07, BMI 26.45 ± 2.69, fasting blood glucose 148.25 ± 33.76) given diabetes self-management education program and divided into two groups. The first group was treated with glibenclamide only and the second was treated with a combination of glibenclamide and metformin. After three months monitoring, 103 patients Completed the study. Therapeutic efficacy was evaluated considering HbA1c ≤ 6.5% as a target value. The necessary statistical study to analyze the data and evaluate the statistical
significance of the results was made.
The results indicate that the treatment supported with life style
modifications was more effective than traditional therapy and patient education at blood glucose control in patients with diabetes mellitus type II and improve their health.
